{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:55:52Z","timestamp":1787025352012,"version":"build-2736575974"},"reference-count":30,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2024-0264","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:13:35Z","timestamp":1724048015000},"page":"353-359","source":"Crossref","is-referenced-by-count":4,"title":["Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?"],"prefix":"10.25122","volume":"17","author":[{"given":"Codru\u021ba Alina","family":"Popescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Human Sciences, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Mihu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cenariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medfuture Research Centre for Advanced Medicine, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015etefan","family":"Vesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Dermatology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Stanca","family":"Melincovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Histology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rare\u015f","family":"Drul\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medfuture Research Centre for Advanced Medicine, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian Bogdan","family":"Tigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Medfuture Research Centre for Advanced Medicine, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Dana","family":"Buzoianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2024,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong AW, Read C","year":"2020","unstructured":"1. Armstrong AW, Read C, Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review, JAMA, 2020;3231945-1960","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamadermatol.2018.5462","article-title":"Association of Atherosclerosis Prevalence with Age, Race, and Traditional Risk Factors in Patients with Psoriasis","volume":"155","author":"Arnold KA, Treister AD, Lio PA, Alenghat FJ","year":"2019","unstructured":"2. Arnold KA, Treister AD, Lio PA, Alenghat FJ, Association of Atherosclerosis Prevalence with Age, Race, and Traditional Risk Factors in Patients with Psoriasis, JAMA Dermatol, 2019;155622-623","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.abd.2020.07.001","article-title":"Blood MicroRNA Expressions in Patients with Mild to Moderate Psoriasis and the Relationship between MicroRNAs and Psoriasis Activity","volume":"95","author":"Alatas ET, Kara M, Dogan G, Ak\u0131n Belli A","year":"2020","unstructured":"3. Alatas ET, Kara M, Dogan G, Ak\u0131n Belli A, Blood MicroRNA Expressions in Patients with Mild to Moderate Psoriasis and the Relationship between MicroRNAs and Psoriasis Activity, An Bras Dermatol, 2020;95702-707","journal-title":"An Bras Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-Regulation of MicroRNA-210 Induces Immune Dysfunction via Targeting FOXP3 in CD4+ T Cells of Psoriasis Vulgaris","volume":"150","author":"Zhao M, Wang L, Liang G, Zhang P, Deng X, Tang Q","year":"2014","unstructured":"4. Zhao M, Wang L, Liang G, Zhang P, Deng X, Tang Q, Up-Regulation of MicroRNA-210 Induces Immune Dysfunction via Targeting FOXP3 in CD4+ T Cells of Psoriasis Vulgaris, Clinical Immunology, 2014;15022-30","journal-title":"Clinical Immunology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cyto.2012.07.031","article-title":"Regulation of Pro-Inflammatory Cytokines TNF\u03b1 and IL24 by MicroRNA-203 in Primary Keratinocytes","volume":"60","author":"Primo MN, Bak RO, Schibler B, Mikkelsen JG","year":"2012","unstructured":"5. Primo MN, Bak RO, Schibler B, Mikkelsen JG, Regulation of Pro-Inflammatory Cytokines TNF\u03b1 and IL24 by MicroRNA-203 in Primary Keratinocytes, Cytokine, 2012;60741-748","journal-title":"Cytokine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jdermsci.2014.05.005","article-title":"MicroRNA-223 and MiR-143 Are Important Systemic Biomarkers for Disease Activity in Psoriasis","volume":"75","author":"L\u00f8vendorf MB, Zibert JR, Gyldenl\u00f8ve M, R\u00f8pke MA, Skov L","year":"2014","unstructured":"6. L\u00f8vendorf MB, Zibert JR, Gyldenl\u00f8ve M, R\u00f8pke MA, Skov L, MicroRNA-223 and MiR-143 Are Important Systemic Biomarkers for Disease Activity in Psoriasis, J Dermatol Sci, 2014;75133-139","journal-title":"J Dermatol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-Term Prognosis in Patients with Psoriasis","volume":"159","author":"Gulliver W","year":"2008","unstructured":"7. Gulliver W, Long-Term Prognosis in Patients with Psoriasis, Br J Dermatol, 2008;1592-9","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?","volume":"2","author":"Sonkoly E, Wei T, Janson PCJ, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M","year":"2007","unstructured":"8. Sonkoly E, Wei T, Janson PCJ, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M, MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?, PLoS One, 2007;2e610","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis Pathogenesis and the Development of Novel Targeted Immune Therapies","volume":"140","author":"Hawkes JE, Chan TC, Krueger JG","year":"2017","unstructured":"9. Hawkes JE, Chan TC, Krueger JG, Psoriasis Pathogenesis and the Development of Novel Targeted Immune Therapies, J Allergy Clin Immunol, 2017;140645-653","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and Clinical Features of Psoriasis","volume":"370","author":"Griffiths CE, Barker JN","year":"2007","unstructured":"10. Griffiths CE, Barker JN, Pathogenesis and Clinical Features of Psoriasis, Lancet, 2007;370263-271","journal-title":"Lancet"},{"issue":"10","key":"ref11","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.4049\/jimmunol.1101817","article-title":"Epidermal CCR6+ \u03b3\u03b4 T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis","volume":"187","author":"Mabuchi T, Takekoshi T, Hwang ST","year":"2011","unstructured":"11. Mabuchi T, Takekoshi T, Hwang ST, Epidermal CCR6+ \u03b3\u03b4 T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis, J Immunol, 2011;187(10):5026-5031","journal-title":"J Immunol"},{"issue":"4","key":"ref12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal Role of Dermal IL-17-Producing \u03b3\u03b4 T Cells in Skin Inflammation","volume":"35","author":"Cai Y, Shen X, Ding C, Qi C, Li K, Li X","year":"2011","unstructured":"12. Cai Y, Shen X, Ding C, Qi C, Li K, Li X, Pivotal Role of Dermal IL-17-Producing \u03b3\u03b4 T Cells in Skin Inflammation, Immunity, 2011;35(4):596-610","journal-title":"Immunity"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/exd.14117","article-title":"The MiR-155\/GATA3\/IL37 Axis Modulates the Production of Proinflammatory Cytokines upon TNF-\u03b1 Stimulation to Affect Psoriasis Development","volume":"29","author":"Wang H, Zhang Y, Luomei J, Huang P, Zhou R, Peng Y","year":"2020","unstructured":"13. Wang H, Zhang Y, Luomei J, Huang P, Zhou R, Peng Y, The MiR-155\/GATA3\/IL37 Axis Modulates the Production of Proinflammatory Cytokines upon TNF-\u03b1 Stimulation to Affect Psoriasis Development, Exp Dermatol, 2020;29647-658","journal-title":"Exp Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/1346-8138.15370","article-title":"MiR-205-5p Inhibits Psoriasis-Associated Proliferation and Angiogenesis: Wnt\/\u03b2-Catenin and Mitogen-Activated Protein Kinase Signaling Pathway Are Involved","volume":"47","author":"Xue Y, Liu Y, Bian X, Zhang Y, Li Y, Zhang Q","year":"2020","unstructured":"14. Xue Y, Liu Y, Bian X, Zhang Y, Li Y, Zhang Q, MiR-205-5p Inhibits Psoriasis-Associated Proliferation and Angiogenesis: Wnt\/\u03b2-Catenin and Mitogen-Activated Protein Kinase Signaling Pathway Are Involved, J Dermatol, 2020;47882-892","journal-title":"J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286344","article-title":"Crosstalk: Keratinocytes and Immune Cells in Psoriasis","volume":"14","author":"Kamata M, Tada Y","year":"2023","unstructured":"15. Kamata M, Tada Y, Crosstalk: Keratinocytes and Immune Cells in Psoriasis, Front Immunol, 2023;14","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2589977513666210707114520","article-title":"IL-23\/Th17 Axis: A Potential Therapeutic Target of Psoriasis","volume":"14","author":"Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK","year":"2022","unstructured":"16. Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK, IL-23\/Th17 Axis: A Potential Therapeutic Target of Psoriasis, Curr Drug Res Rev, 2022;1424-36","journal-title":"Curr Drug Res Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejcb.2012.11.002","article-title":"MiR-205 in Cancer: An Angel or a Devil?","volume":"92","author":"Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang SZ","year":"2013","unstructured":"17. Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang SZ, MiR-205 in Cancer: An Angel or a Devil?, Eur J Cell Biol, 2013;9254-60","journal-title":"Eur J Cell Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2007.03.201","article-title":"MicroRNA Expression Profiles in Head and Neck Cancer Cell Lines","volume":"358","author":"Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O\u2019Brien C","year":"2007","unstructured":"18. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O\u2019Brien C, MicroRNA Expression Profiles in Head and Neck Cancer Cell Lines, Biochem Biophys Res Commun, 2007;35812-17","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?","volume":"2","author":"Sonkoly E, Wei T, Janson PCJ, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M","year":"2007","unstructured":"19. Sonkoly E, Wei T, Janson PCJ, S\u00e4\u00e4f A, Lundeberg L, Tengvall-Linder M, MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?, PLoS One, 2007;2e610","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3677","article-title":"Silencing of MiR 155 Suppresses Inflammatory Responses in Psoriasis through Inflammasome NLRP3 Regulation","author":"Luo Q, Zeng J, Li W, Lin L, Zhou X, Tian X","year":"2018","unstructured":"20. Luo Q, Zeng J, Li W, Lin L, Zhou X, Tian X, Silencing of MiR 155 Suppresses Inflammatory Responses in Psoriasis through Inflammasome NLRP3 Regulation, Int J Mol Med, 2018;","journal-title":"Int J Mol Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e20916","DOI":"10.1371\/journal.pone.0020916","article-title":"MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of Hsa-MiR-99a and IGF-1R","volume":"6","author":"Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B","year":"2011","unstructured":"21. Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B, MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of Hsa-MiR-99a and IGF-1R, PLoS One, 2011;6e20916","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 Overexpression Promotes Psoriasis-like Inflammation by Inducing Th1 and Th17 Cell Differentiation","volume":"128","author":"Wu R, Zeng J, Yuan J, Deng X, Huang Y, Chen L","year":"2018","unstructured":"22. Wu R, Zeng J, Yuan J, Deng X, Huang Y, Chen L, MicroRNA-210 Overexpression Promotes Psoriasis-like Inflammation by Inducing Th1 and Th17 Cell Differentiation, J Clin Invest, 2018;1282551-2568","journal-title":"J Clin Invest"},{"issue":"5","key":"ref23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-4362.1994.tb01073.x","article-title":"Histologic grading system for psoriasis vulgaris","volume":"33","author":"Trozak DJ","year":"1994","unstructured":"23. Trozak DJ, Histologic grading system for psoriasis vulgaris, Int J Dermatol, 1994;33(5):380-381","journal-title":"Int J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/adt.2023.014","article-title":"Psoriasis: Striving for Potential Biomarkers","volume":"21","author":"Dan D, Srivastava N","year":"2023","unstructured":"24. Dan D, Srivastava N, Psoriasis: Striving for Potential Biomarkers, Assay Drug Dev Technol, 2023;21235-257","journal-title":"Assay Drug Dev Technol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","article-title":"MicroRNAs and Potential Target Interactions in Psoriasis","volume":"58","author":"Zibert JR, L\u00f8vendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L","year":"2010","unstructured":"25. Zibert JR, L\u00f8vendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L, MicroRNAs and Potential Target Interactions in Psoriasis, J Dermatol Sci, 2010;58177-185","journal-title":"J Dermatol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2478\/acph-2019-0047","article-title":"A Modern Approach to the Treatment of Plaque Psoriasis","volume":"69","author":"Drvar DL, Vlahini\u0107 T, Male\u0161 \u017d, Tur\u010di\u0107 P, \u010ceovi\u0107 R","year":"2019","unstructured":"26. Drvar DL, Vlahini\u0107 T, Male\u0161 \u017d, Tur\u010di\u0107 P, \u010ceovi\u0107 R, A Modern Approach to the Treatment of Plaque Psoriasis, Acta Pharmaceutica, 2019;69511-523","journal-title":"Acta Pharmaceutica"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: From Pathogenesis to Targeted Therapies","volume":"54","author":"Conrad C, Gilliet M","year":"2018","unstructured":"27. Conrad C, Gilliet M, Psoriasis: From Pathogenesis to Targeted Therapies, Clin Rev Allergy Immunol, 2018;54102-113","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"ref28","first-page":"9224","article-title":"miR-205 and HMGB1 expressions in chronic periodontitis patients and their associations with the inflammatory factors","volume":"13","author":"Jiang F, Zhou Y, Zhang R, Wen Y","year":"2021","unstructured":"28. Jiang F, Zhou Y, Zhang R, Wen Y, miR-205 and HMGB1 expressions in chronic periodontitis patients and their associations with the inflammatory factors, Am J Transl Res, 2021;13(8):9224-9232","journal-title":"Am J Transl Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3390\/cells10102547","article-title":"MiR-21-3p\/IL-22 Axes Are Major Drivers of Psoriasis Pathogenesis by Modulating Keratinocytes Proliferation-Survival Balance and Inflammatory Response","volume":"10","author":"Abdallah F, Henriet E, Suet A, Arar A, Clemen\u00e7on R, Malinge J-M","year":"2021","unstructured":"29. Abdallah F, Henriet E, Suet A, Arar A, Clemen\u00e7on R, Malinge J-M, MiR-21-3p\/IL-22 Axes Are Major Drivers of Psoriasis Pathogenesis by Modulating Keratinocytes Proliferation-Survival Balance and Inflammatory Response, Cells, 2021;102547","journal-title":"Cells"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/exd.13888","article-title":"MiR-744-3p Regulates Keratinocyte Proliferation and Differentiation via Targeting KLLN in Psoriasis","volume":"28","author":"Wang C, Zong J, Li Y, Wang X, Du W, Li L","year":"2019","unstructured":"30. Wang C, Zong J, Li Y, Wang X, Du W, Li L, MiR-744-3p Regulates Keratinocyte Proliferation and Differentiation via Targeting KLLN in Psoriasis, Exp Dermatol, 2019;28283-291","journal-title":"Exp Dermatol"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-3-2024\/original-article-issue-3-2024\/is-mir-205-a-possible-biomarker-for-evaluating-treatment-response-in-psoriasis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:14:50Z","timestamp":1724048090000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-3-2024\/original-article-issue-3-2024\/is-mir-205-a-possible-biomarker-for-evaluating-treatment-response-in-psoriasis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["JMedLife-17-353"],"URL":"https:\/\/doi.org\/10.25122\/jml-2024-0264","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}